AbSci says its genetically engineered E. coli expression platform has produced yields exceeding 20 g/L for difficult to express products and threatens the dominance of mammalian systems.
Read the full article here: biopharma-reporter.com
AbSci hopes to make E. Coli great again through engineered expression system
